Comprehensive
Heart Health Analytics
for Greater Longevity
Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events
We deliver a holistic approach to prevent heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms
Monitor
Cloud solution for affordable real-time remote heart health monitoring through any leads digital ECG device integration
Analyze
Clinically proven machine-learning algorithms that analyze up to 400 vital ECG parameters and detect all types of Arrythmias, Atrial Fibrillation, Myocardial Infarction, Ventricular Hypertrophy
Predict
Patent-pending Universal ECG and Personal Baseline Scores to precisely predict heart attacks and strokes up to 2 months before they occur
Prevent
Personalized reports on vital cardiac parameters values to timely adjust medication and patient's lifestyle, increasing access to preventive care
Remote Real-time Heart Health Monitoring
Allows to accurately determine the position of every cardiac parameter on a scale from a personal baseline to pathology to prevent dangerous heart events for elevated risk groups
Diabetes Cardiovascular Comorbidities Prevention
Provides an integrated solution for primary prevention of cardiovascular complications in diabetes with specific cardiac parameters monitoring, timely disease CVD risk detection and cure
Fatigue Risk Management
Comprehensive liability insurance solution and alert system for seamless real-time fatigue risks monitoring in critical safety job performers to prevent further accidents
Benefits
for corporate sector
Comprehensive clinically-proven and CE-certified, yet affordable tracking of all-known vital parameters to ease and speed-up the patient diagnosticating for cardiologists, general practitioners and healthcare providers
Healthcare system cost burden reduction, driven by eliminated physician office visits, dangerous heart events and hospital readmission prevention with timely cardiovascular risk detection and early treatment intervention
Plain, patient- and doctor-adapted visually compelling cardiac health reports, enabling patients to take control of and positively impact their health with necessary lifestyle adjustments
Team
Meet our health passionate and expert global team, standing behind the Cardiolyse platform development and growth
Advisory Board
Pulli Global Development Advisor Executive with 25+ years of experience in Business Development (ex-CEO Chiezi)
Pirttiaho Global Development Advisor MedTech solutions growth expert with 15+ years in sales for large and small ventures
Gualerzi Scientific Advisor Experienced medical director and cardiologist, leading non-profit's and corporate scientific divisions
News
Cardiolyse Was Honored to Present Our Technology At European Society of Cardiology Congress in Paris
World’s biggest cardiology event – European Society of Cardiology (ESC) Congress in Paris has been a great success. More than 33,000 health professionals gathered over five days to attend 600 expert sessions covering the entire spectrum of cardiovascular medicine, visit the sessions showcasing 28 key clinical trials, share knowledge and global scientific experience, learn and gain new advances, network and […]
Read more
CEO of Cardiolyse Presented Fatigue Risk Management Solution at Connected Health Tech Meeting in Paris
Keep on exploring our solution expansion opportunities, this time in France Thank you Paris Region for the invitation and amazing opportunity to take part in and pitch at the Connected Health Tech Meeting event, that took place in Paris last week. Our CEO, Anna Starynska has presented Cardiolyse innovative products for remote real-time Heart Health monitoring for high risk groups, […]
Read more
Cardiolyse Joined British-Ukrainian Tech Night as a Part of London Tech Week
British-Ukrainian Tech Night has been just great! Our CTO Nick Papirniy has presented Cardiolyse to the 200+ audience of both Ukrainian and British tech communities, investors, entrepreneurs and corporates, government officials and partnering startups. We’re excited to have earlier won such an opportunity to pitch and now to have become a part of such a vibrant and innovation-driven event! This […]
Read more
Cardiolyse Joined Global Community of Healthcare Companies at the Tech Tour’s Digital Health Venture Forum
Last week our CMO Masha Nerobeieva has presented Cardiolyse to a global community of healthcare companies and investors at the Tech Tour’s Digital Health Venture Forum in Porto, Portugal. The Forum gathered more than 170 participants, including presenting companies from across 11 countries, international and regional investors, health sector corporates, industry players and the state officials. Cardiolyse was selected out […]
Read more
Cardiolyse Successfully Finished the Stage 2 Audit for ISO 13485 and CE as a Medical Software Certification
An amazing end of the intense week and the challenging last months overall. Cardiolyse has successfully finished the stage 2 audit for ISO 13485 and CE as a medical software certification. CE is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area. CE is essential to fully enter […]
Read moreSend us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement